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Introduction
Around 50% of all familial breast and ovarian cancers are
due to mutations in BRCA1 and BRCA2. Germline muta-
tions in the BRCA2 gene are associated with an increased
susceptibility to breast cancer (in both males and females)
and they also confer an increased risk of early onset ovarian,
prostate, and pancreatic cancer. The biological function of
BRCA2 in the cell is still uncertain, although there is
increasing evidence for a role in the repair of DNA by
homologous recombination. BRCA2 and RAD51 (a
homolog of the baterial recombination protein RecA) both
co-localise to nuclear foci thought to be sites of DNA
damage and repair and these nuclear foci fail to form in
BRCA2 deficient cells. Loss of BRCA2 leads to error prone
repair of double strand DNA breaks and in dividing cells can
lead to chromosomal abberations and loss of genetic infor-
mation. Compelling evidence of a more direct role for
BRCA2 in DNA repair is provided by two recent studies
investigating some of the protein’s structural interactions.
Structural interactions of BRCA2
In an exceptional publication in Science [1], Yang and col-
leagues demonstrate the crystal structure of the 800-
residue carboxyl-terminal domain of BRCA2 that lies
beyond the sequence of highly conserved BRC motifs
(sets of amino acid repeats in the centre of BRCA2). This
carboxyl-terminal region is likely to play an important role in
the tumour suppressor function of BRCA2 as it corre-
sponds to the most conserved portion of BRCA2 across
different species and contains 27% of tumour-derived
missense mutations. The authors strengthen this hypothe-
sis by presenting the 3.1 angstrom structure of the car-
boxyl-terminal domain bound to another protein, DSS1
(deleted in split hand/split foot syndrome), and show that
this structure contains multiple areas similar to single
stranded and double stranded DNA binding motifs. They
also show that this domain of BRCA2 can bind to single
stranded DNA and stimulate RAD51 mediated recombina-
tion  in vitro. Their data thus indicate a direct role for
BRCA2 in homologous recombination and provide a
structural insight into the loss of recombination mediated
DNA repair in BRCA2 associated cancers.
Pellegrini and colleagues from Cambridge University
explore further the structural interactions between BRCA2
and RAD51 and their role in DNA repair [2]. This paper
reports for the first time the crystal structure of the
complex between a BRC repeat and the catalytic domain
of RAD51. The BRC repeat is found to mimic a motif in
RAD51 that serves as an interface between adjacent
RAD51 monomers. Through molecular mimicry, BRCA2
may therefore control the formation of the RAD51 nucleo-
protein filament, which is essential for DNA recombination.
This provides a structural basis for the BRCA2 regulation
of RAD51 function and explains how BRCA2 mutations
may disrupt the predicted interactions between BRC and
RAD51 and cause increased cancer susceptibility.
Conclusion
Both studies outlined demonstrate the importance of
structural analyses to further knowledge of protein func-
tion. They provide direct evidence for the role of BRCA2 in
DNA repair and also a structural basis for the loss of
recombination-mediated double strand DNA break repair
in BRCA2-associated cancers. The challenge now is to
take advantage of this deficiency in homologous recombi-
nation to specifically target and destroy BRCA2 mutant
cells in cancer patients.
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